GLP-1 hair loss: why it happens on Ozempic, Wegovy and Mounjaro, and what helps
Hair loss is a listed side effect. In label trials it was reported by 3.3% of adults on Wegovy 2.4 mg and 4–5% on Zepbound vs about 1% on placebo, mostly women, and both labels link it to weight reduction. It usually looks like telogen effluvium: diffuse shedding about 2–3 months after a trigger that often settles within months. Don't stop treatment on your own; talk to your doctor.
Does GLP-1 medication cause hair loss?
It can, although most people in the trials didn’t report it. Hair loss appears in the US prescribing information for both main weight-management GLP-1 medicines, and in both labels the hair-loss reports were associated with weight reduction.
- Wegovy (semaglutide). In pooled 68-week adult trials, hair loss was reported by 3.3% of people on 2.4 mg and 1% on placebo. Women reported it far more often than men (4% vs 0.9%). In the trials of the newer 7.2 mg dose, the figure was 5.8%, compared with 3.3% on 2.4 mg and 1.0% on placebo.
- Zepbound (tirzepatide). In SURMOUNT-1 and -2, hair loss was reported by 5%, 4% and 5% of people on 5, 10 and 15 mg, versus 1% on placebo. Again it skewed female: 7.1% of women vs 0.5% of men on Zepbound. No Zepbound-treated participant stopped treatment because of it.
- Ozempic and Mounjaro. Their diabetes labels list alopecia only under postmarketing reports. Those reports are voluntary, so neither label gives a rate or confirms the medicine as the cause.
Why does hair fall out on Ozempic or Mounjaro?
The leading explanation isn’t the medicine attacking hair follicles. It’s a well-known reaction to losing weight quickly, called telogen effluvium.
At any moment, roughly 90% of scalp hairs are in the growing phase and about 10% are resting, according to a 2020 dermatology review. A significant physical stress can push many growing hairs into the resting phase at the same time. They don’t fall out straight away; they shed later, together, which is why the change can feel sudden.
Recognised triggers include surgery, high fever, illness, childbirth, thyroid disease and diet-related stress such as calorie restriction or severe protein deficiency. The American Academy of Dermatology (AAD) lists losing 20 pounds or more among the common triggers. A 2025 scoping review of GLP-1 medicines and alopecia proposes this same mechanism: rapid weight loss acts as a metabolic stressor, much like the shedding seen after bariatric surgery or strict low-calorie diets. The review adds that, in people already predisposed, these medicines might also bring pattern hair loss (androgenetic alopecia) forward.
Keep the evidence in perspective. That review found only nine studies, most of which didn’t have a dermatologist confirm the type of hair loss, and the authors say a causal link can’t yet be established.
When does GLP-1 hair loss start, and how long does it last?
Timing
Telogen effluvium typically begins about 2–3 months after the trigger. That lag is why shedding tends to show up a few months into treatment rather than in the first weeks, and why it can feel disconnected from anything you did recently.
Some shedding is normal: the AAD puts it at 50 to 100 hairs a day. Telogen effluvium is usually diffuse, meaning more hair in the shower drain, on your pillow or in your brush, and an overall thinner feel, rather than bald patches.
Will it grow back?
For most people it does, although there are no long-term regrowth studies specific to GLP-1 users. Acute telogen effluvium is defined as lasting less than six months, and the 2020 review reports that it remits in about 95% of cases. The AAD says that once the body readjusts, hair usually returns to its normal fullness within six to nine months, but shedding can continue for longer if the stress keeps going.
Shedding that persists for more than six months is classed as chronic and deserves a proper evaluation.
How can you reduce hair loss on a GLP-1?
No step is proven to prevent telogen effluvium entirely, but these address the most common contributors.
1. Eat enough, especially protein
When appetite drops, it’s easy to slide into the kind of calorie and protein shortfall the hair cycle is sensitive to. The AAD advises against eating too few calories when hair is shedding. Put protein first at each small meal: our guide to setting a protein target on a GLP-1 covers how much and how to reach it on low-appetite days, and what to eat on a GLP-1 shows how to build small but complete meals.
2. Ask your doctor what to check
Thyroid disease and severe zinc deficiency are recognised triggers, and low iron and vitamin D have also been linked to shedding, though that evidence is mixed. Rather than guessing, ask your doctor whether to check ferritin (iron stores), vitamin D, thyroid function and, if your diet or history suggests it, zinc. Our article on doctor visits and lab tests on a GLP-1 explains how to prepare for that conversation.
A few cautions on supplements:
- The AAD recommends a blood test before taking hair supplements and notes that too much selenium, vitamin A or vitamin E has been linked to hair loss. Megadoses can backfire.
- A 2019 review in Dermatology and Therapy found no evidence that biotin helps hair in people who aren’t deficient, and biotin can distort some lab results. Tell your doctor if you take it before any blood test.
- The same review notes there is no agreed ferritin cut-off for hair, and the case for iron or vitamin D supplements rests mainly on a confirmed deficiency. Let your clinician interpret results and decide on doses.
3. Treat your hair gently while it sheds
These AAD tips reduce breakage, which can make thinning look worse:
- Use a gentle shampoo followed by conditioner, and air-dry or use a microfiber towel when you can.
- Keep the blow-dryer on its lowest setting and save flat irons and curling irons for special occasions.
- Avoid tight ponytails, buns and braids, which can cause traction alopecia.
- Brush gently, and skip at-home colouring, perms and relaxers for now.
- If you smoke, quitting helps; smoking can worsen hair loss.
4. Don’t stop or change your dose on your own
In the trials, hair loss rarely led anyone to stop treatment. If it bothers you, talk to your prescriber, who can look at your pace of weight loss, your nutrition and your dose plan together. Dose decisions belong with them.
When should you see a doctor or dermatologist about hair loss?
Diffuse shedding a few months after starting a GLP-1 is common and usually temporary. Book an appointment with your doctor or a dermatologist if you notice:
- Patchy loss: a bald patch or strip appearing within a day or two, or clumps of hair coming out when you brush
- Scalp symptoms: intense itching, burning, tenderness, scaling, sores or pus where hair is thinning
- Loss beyond the scalp: eyebrows, eyelashes or beard
- Progressive thinning: a receding hairline, widening part or thinning crown that keeps getting worse
- Shedding that lasts more than six months, or keeps accelerating
- Eating very little because of persistent nausea or vomiting
The AAD advises seeing a board-certified dermatologist early if you’re worried, since some types of hair loss respond better when treated sooner.
The takeaway
Hair loss on a GLP-1 is real but reported by a minority in trials, mostly women, and it usually reflects the weight loss itself. It typically starts 2–3 months after the trigger and often settles within months. Eating enough protein, checking for deficiencies with your doctor and handling your hair gently are the practical levers.
Tracking helps you connect the dots. In GLPMate you can log shedding with a severity rating in the side-effect log, see it alongside your weight trend and protein intake, and take a doctor report (PDF) to your appointment. This article is educational only and not medical advice — talk to your doctor or dermatologist about hair loss that worries you.
FAQ
Does Ozempic cause hair loss?
Ozempic's label lists alopecia among postmarketing reports, which means how often it happens can't be estimated from that label. Wegovy contains the same medicine, semaglutide, and in its weight-management trials hair loss was reported by 3.3% of adults on 2.4 mg vs 1% on placebo, mostly women. The label links these reports to weight reduction.
Does Mounjaro or Zepbound cause hair thinning?
In Zepbound's SURMOUNT-1 and -2 trials, 4–5% of participants reported hair loss vs 1% on placebo, and women reported it far more often than men (7.1% vs 0.5%). No one on Zepbound stopped treatment because of it. Mounjaro has the same active ingredient, tirzepatide, and its label lists alopecia among postmarketing reports.
Does GLP-1 hair loss grow back?
It usually behaves like telogen effluvium, and a dermatology review reports that the acute form remits in about 95% of cases. The American Academy of Dermatology says hair typically regains its usual fullness within 6–9 months once the body readjusts. If shedding lasts more than 6 months, comes in patches, or your scalp is itchy or sore, see a doctor or dermatologist.
How do I stop hair loss on a GLP-1?
There's no guaranteed fix, but eating enough protein and calories, asking your doctor whether to check ferritin, vitamin D and thyroid function, and handling your hair gently address the most common contributors. Avoid high-dose supplements without a confirmed deficiency, since too much vitamin A, selenium or vitamin E can worsen hair loss. Don't stop or change your dose without your prescriber.
Sources
- Novo Nordisk, WEGOVY (semaglutide) US Prescribing Information, revised 06/2026 — section 6.1, Hair Loss — hair loss in 3.3% on 2.4 mg vs 1% on placebo (pooled 68-week adult trials; 4% of women vs 0.9% of men); 5.8% on 7.2 mg; reports associated with weight reduction
- Eli Lilly, ZEPBOUND (tirzepatide) US Prescribing Information, revised 02/2026 — Table 1 and section 6.1, Hair Loss — hair loss in 5%, 4% and 5% on 5, 10 and 15 mg vs 1% on placebo (SURMOUNT-1 and -2); 7.1% of women vs 0.5% of men; no Zepbound-treated patient stopped for hair loss
- OZEMPIC (Novo Nordisk, revised 05/2026) and MOUNJARO (Eli Lilly, revised 08/2026) US Prescribing Information — section 6.2, Postmarketing Experience — alopecia listed among voluntary postmarketing reports; frequency and causality cannot be reliably established
- Asghar et al., Cureus 2020 — Telogen Effluvium: A Review of the Literature — about 90% of scalp hairs growing and 10% resting; shedding about 2–3 months after a trigger; diet-related triggers incl. caloric restriction and severe protein or zinc deficiency; acute form under 6 months, remits in about 95%; chronic over 6 months
- Rojas Lopez et al., Cureus 2025 — Alopecia as an Emerging Adverse Effect Associated With GLP-1 Receptor Agonists for Weight Loss: A Scoping Review — nine studies; rapid weight loss as a likely telogen effluvium trigger; possible unmasking of pattern hair loss; most studies lacked dermatologic confirmation and causality is not established
- Almohanna et al., Dermatology and Therapy 2019 — The Role of Vitamins and Minerals in Hair Loss: A Review — no consensus ferritin cut-off; supplementation evidence tied to documented deficiency; no evidence biotin helps without deficiency and biotin can distort lab tests
- American Academy of Dermatology — Hair shedding; Hair loss: Tips for managing; Hair loss: Signs and symptoms — 50–100 hairs a day is normal; losing 20 lb or more is a common trigger; fullness usually returns in 6–9 months; gentle hair-care tips; excess selenium, vitamin A or E linked to hair loss; warning signs such as sudden patches and scalp burning
Sources checked:
This article is educational and is not medical advice, diagnosis or treatment. Medication decisions — including dose changes and what to do after a missed dose — belong with your prescriber. If you experience severe symptoms, seek medical care.